Compare
Syra Health Corp vs Baiya International Group Inc.
| Latest fiscal year | Syra Health Corp SYRA | Baiya International Group Inc. BIYA |
|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 |
| Revenue | $7.23M | $16.48M |
| Revenue growth (YoY) | -9.5% | +28.6% |
| Gross margin | 34.4% | 11.5% |
| Operating margin | -12.5% | -58.1% |
| Net margin | -12.4% | -57.8% |
| Net income | -$896.3K | -$9.53M |
| EPS (Diluted) | -$0.08 | -$5.04 |
| Operating cash flow | -$447.7K | -$7.44M |
| Free cash flow | -$447.9K | -$7.44M |
| Cash & equivalents | $1.61M | $688.9K |
| Total assets | $2.77M | $27.83M |
| Total liabilities | $674.7K | $4.76M |
| Shareholders' equity | $2.10M | $23.07M |
| Return on year-end equity | -42.7% | -41.3% |
| Shares outstanding | n/a | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Syra Health Corp | Baiya International Group Inc. |
|---|---|---|
| Latest | $7.23M Ended 2025-12-31 | $16.48M Ended 2025-12-31 |
| 1 year earlier | $7.98M Ended 2024-12-31 | $12.81M Ended 2024-12-31 |
| 2 years earlier | $5.52M Ended 2023-12-31 | $11.57M Ended 2023-12-31 |
| 3 years earlier | $5.62M Ended 2022-12-31 | $13.16M Ended 2022-12-31 |
| 4 years earlier | n/a | n/a |